Nisa Investment Advisors, LLC Oncocyte Corp Transaction History

Nisa Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.86 - $1.53 $72,556 - $129,083	-84,368 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$1.15 - $2.25 $40,976 - $80,172	-35,632 Reduced 29.69%	84,368 $126,000
Q4 2020 Jan 25, 2021	BUY	$1.38 - $2.63 $165,600 - $315,600	120,000 New	120,000 $287,000
Q3 2020 Oct 20, 2020	SELL	$1.2 - $1.89 $1,890 - $2,976	-1,575 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$1.91 - $3.45 $1,251 - $2,259	655 Added 71.2%	1,575 $3,000
Q1 2020 Apr 17, 2020	BUY	$1.76 - $3.02 $1,619 - $2,778	920 New	920 $2,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $260M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.